Cobra Bio-manufacturing Share Discussion Threads

[the_doctor] 11/5/2009 10:25

jdb, stop posting lies!

It says
'the third party has withdrawn with immediate effect'

The company NEEDS new orders just to survive, that wont cause a rerating unless sufficient

Any further delays (they've already had some) or failure to get enough orders and this is bust. To pretend otherwise is foolish.

[jdb2005] 11/5/2009 09:53

CEO no fool and has decided to terminate talks rather than waste mgt. time.

Happy to hold my stock for rerating which will follow with new orders.

[alibongo612] 11/5/2009 09:44

Let's hope they didn't walk away because they were unimpressed

[the_doctor] 11/5/2009 07:47

"It looks to me as though Cobra have decided that they are better off staying independent"

Yes, it would look that way to ole rose eyes!

jdb, it wouldnt do you any harm to at least consider negatives sometimes and allow for their possibility!
Hopefully your unbalanced posts didnt con anyone into buying at 4.25p.

Again, sorry it didnt work out (or hasnt yet). My comments are not any form of gloating. I also hope that not succumbing to a bid is the best thing for Cobra and its employees.

[jdb2005] 11/5/2009 07:39

It looks to me as though Cobra have decided that they are better off staying independent of this pharma who were being opportunistic when it thought CBF was at its lowest point.

My assessment still stands that CBF will be announcing more orders this year especially as it has invested in further equipment at Oxford and are likely to reach a settlement with GenVec.

[hyper al] 11/5/2009 07:28

the ups and downs of business

[the_doctor] 11/5/2009 07:14

"On 07 April 2009 the Company announced that it was in preliminary talks with a third party regarding a potential offer for the Company. The Company has been informed that the third party has withdrawn with immediate effect and
accordingly, the Company is no longer in an offer period pursuant to the City
Code on Takeovers and Mergers"

Like I said jbd, there were risks, that you tried to ignore.

This comment of yours less than 24hrs looks rather daft now, sorry

"The significance of their last RNS has not be realised by PIs yet. Company is at preliminary stage of talks with third party that may/may not lead to a deal"

All said though, it is possible that CBF are so confident of new orders that they told the party they'd reject a bid and hence the party withdrew.
Who knows

[jdb2005] 10/5/2009 18:37

Ignore Phoney - he just cannot get used to looking over the fence at my tips which I have been posting on the SLN thread - 75% or more have come good in last 3 months.
I put my money where my mouth is - I bought CBF at 1.75p, 2p, 2.45p. and believe it is still undervalued at 4.25p.

DYOR everyone and remember what I have said. New CEO has been turning this company around, order book is filling up and there are better times ahead at CBF. The significance of their last RNS has not be realised by PIs yet. Company is at preliminary stage of talks with third party that may/may not lead to a deal.
Their statement about GenVec indicated that they had not included any income from that contract in their published accounts. CEO has said he hopes to be able to resolve issues by end of June 2009.

[the_doctor] 01/5/2009 08:33

I'm not the one that lives a life of spin and lies jdb.

[dpmcq] 30/4/2009 21:41

The £11 million is not for a quater it is for half year I think.

[jdb2005] 30/4/2009 14:40

Admit it phoney you have a serious problem.

[jdb2005] 30/4/2009 08:46

Why do you try to quote things out of context?? I know Cobra is small by size but the point I have made is that they have a new CEO who has made several improvements. The Company has a growing order book, £11m in first quarter is no mean feat for a small company, so I can see it will start trading profitably. It also could be why a third party has appeared on the scene.
Your comments - it will run out of money soon - it will have orders cancelled show your lack of understanding of the real world.

We will look back in the months ahead and see who is astute and wiser.

[the_doctor] 30/4/2009 08:25

jdb

You specifically said Tamiflu, not clinical trial material:

"I can see major panic setting in as currently Roche are struggling to supply Tamiflu vaccines to meet world demand.

Perhaps we will see major pharmas turning to smaller manufacturers to help fulfil orders."


Fair enough, that the emergence of swine flu might push pharmas to start new vaccine programmes, some of which could end up at Cobra - but that wasnt what you said. Equally, they could ditch other existing orders with Cobra to switch to flu vaccines with someone else (but I'm not considering that).

The point was you were originally trying to make out that Cobra could help to 'fulfill orders'. For the reasons I have stated, this is unlikely and you were just ramping.

(yet of course, despite yet again showing yourself up as not understanding, you continue to make silly comments about my level of research!)
I'm not trying to have a go at you, but simply to stop any poster (it just happened to be you) from making up rubbish on the back or recent world news.

[jdb2005] 30/4/2009 08:00

D*c your hypothesis is unfounded - Cobra use their plants to provide short run production of vaccines for pharmas entering clinical trials which often involve novel treatments. Customers pay a premium for this work.
They have several new customers and through their investment in Oxford facilities expect to be trading profitably. Their order book of £11m in first quarter of 2009 looks impressive. Compare it with this time last year.

Perhaps you need to do more research before making judgements here.

[the_doctor] 29/4/2009 18:25

jdb

Tamiflu for example is manufactured using LARGE bacterial fermenters and similarly large downstream reactors.

Cobra almost certainly doesnt have any sort of capacity approaching this

Similarly, Cobra's focus is on clinical material and earlier

Roche (in this case) would not start using its biologics pilot plant to produce Tamiflu, shifting prior plans to Cobra. The fit is just not there, but you've never worked in a pharma, have you?

So, tell us, how would Roche or Novartis' use of large scale equipment have ANY bearing on the equipment that compete's for time with Cobra's?


IN SHORT, you clearly do not understand that production and development work (of the sort that Cobra does) largely takes place in different equipment. There could be some scheduling conflicts that result, but it would require a good dose of luck for it to push extra work Cobra's way. Possible, but unless you know some detail, it's unlikely.

[alibongo612] 29/4/2009 13:54

girls please spare us from your spat

[jdb2005] 29/4/2009 10:19

D*c - What is this ???" Cobra most likely overlaps with their smaller scale pilot and biologics equipment"

You have not got a clue. You have no interest here other than to try to make ridiculous comments - get back to MDX and your personal thread !!

[the_doctor] 29/4/2009 09:45

"but as they ramp up production their capacity to do more development work diminishes"

Possibly, but Cobra most likely overlaps with their smaller scale pilot and biologics equipment, than whatever Roche and co. will be using for their antivirals.

Yet again jdb, you talk nonsense, then when challenged, accuse others of ramping/deramping and making silly comments about other stocks.

[jdb2005] 29/4/2009 09:40

Boadicea - Yes they have some good IPs to exploit but manufacturing deals will drive the share price back to double figures. IMHO now is the best time to accummulate if you can.

[boadicea] 28/4/2009 19:02

I think the more likely pay-off for CBF would arise not from volume production in its own labs but from the choice of one of its techniques to be used under licence by a larger producer. That is where the most profitable deals can arise.

[jdb2005] 28/4/2009 18:17

D*c - wash those ears out - indirectly means not expecting Roche GSK or Novartis to give Cobra work but as they ramp up production their capacity to do more development work diminishes.
Cobra has £11m of orders far better situation than this time last year so I'm expecting them to have a profitable 2009.

You must stick to what you know and wait for your biotechs to come good.
See you are also spending a lot of time ramping two other stocks - guess you have funds tided up there now.

[the_doctor] 27/4/2009 16:44

Swine flu hasnt exactly changed the face of pharma
IF Cobra happened to get lucky in getting involved with some work relating to new vaccines... but the likelihood of that area suddenly just happening to result in an order going to Cobra seems slim

The point was that Cobra wont IMO play any role in helping Roche or Novartis fulfil orders in the way you implied in 4325

[jdb2005] 27/4/2009 14:02

D*c where are you coming from?? Cobra would not have capacity to produce swine flu vaccine but it could benefit indirectly given its current line of business.